The sales of hypnotic and sedative medicines in Canada are forecasted to slightly decline over the next five years, from $151.7 million in 2024 to $149.1 million in 2028. This indicates a gradual market contraction after witnessing steady performance previously. In 2023, actual figures revealed stabilization around the $152 million mark. Year-on-year analysis suggests a decreasing trend with minor fluctuations, and a negative compound annual growth rate (CAGR) reflects this downtrend.

Future trends to watch for include:

Regulatory changes and healthcare policies impacting prescribing practices.
Increasing awareness and alternatives like holistic and non-pharmacological treatments.
Technological advancements altering production and distribution efficiencies.